StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Earnings

Northwest Biotherapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Northwest Biotherapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2013ended Jun 30, 2013Aug 9, 2013before the open–––Filing
Q1 FY2013ended Mar 31, 2013Apr 8, 2013during market hours–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Northwest Biotherapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Northwest Biotherapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

See a number that looks wrong?